Target intelligence / Profile preview

CEBPZ antisense RNA 1 (CEBPZ-AS1)

Target
CEBPZ-AS1
Molecular classification
Other (Antisense non-coding RNA), Possibly mitochondrial protein (limited literature support)
01

Overview

CEBPZ opposite strand (CEBPZOS, CEBPZ-AS1) encodes an antisense RNA transcript to the CEBPZ gene and is expressed in various tissues. Emerging limited studies indicate that CEBPZOS may localize to mitochondria and participate in energy metabolism; its function in tumor cells (notably liver cancer) has been linked with mitochondrial activity and possibly tumor growth, though its precise molecular mechanisms remain unclear and little mechanistic data is available. CEBPZOS should not be confused with the protein transcription factor CEBPZ, which is a distinct DNA-binding protein involved in hematopoiesis and tumor suppression. There is insufficient evidence to consider CEBPZOS a canonical druggable target or receptor at this time. The nomenclature is occasionally inconsistent in the literature, and "protein CEBPZOS" is not widely accepted or validated as an official molecular entity. CEBPZOS is not a standard therapeutic target; it is an antisense RNA (possible lncRNA) with very limited functional annotation, a paucity of mechanistic studies, and ambiguity about its role as an independent protein. Most of the well-characterized functions and disease associations pertain to the sense strand gene, CEBPZ (CCAAT/enhancer binding protein zeta), not CEBPZOS.

Other names
CEBPZ opposite strandCEBPZOSCEBPZ-AS1CEBPZ antisense RNA 1Protein CEBPZOS (rare, not standard)
02

Mechanism of action

Not applicable (no known drugs; mechanism speculative, possibly related to regulation of mitochondrial metabolism or RNA interference of CEBPZ)

03

Biological functions

Regulation of gene expression (as antisense RNA, likely modulates CEBPZ transcription/translation)Possible roles in mitochondrial energy metabolism (limited experimental evidence)
04

Disease associations

Cancer (possible involvement in tumor cell metabolism and development, especially in liver cancer; broader roles not established)Other (potential but unproven role in other disease contexts)

Beyond the preview

Go deeper on CEBPZ antisense RNA 1 (CEBPZ-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CEBPZ antisense RNA 1 (CEBPZ-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call